Skincare company CellDerma has released a brand-new product – the GF5 Next Gen serum.
The company explains that GF5 Next Gen uses growth factors, ceramides, neuropeptides, palmitotyl tripeptide-8 and copper tripeptide-1 peptides, calcium alpha-hydroxymethionine and homotaurine to address signs of ageing including fine lines and wrinkles, promote skin regeneration, repair the skin barrier and improve overall skin health.
Dr Dev Patel, aesthetic practitioner and founder of CellDerma, said, “When we launched GF5, it challenged everything that people thought was possible from a single serum. It is a cosmetic product and therefore, we can make no medical claims. However, in the course of clinical practice, practitioners – including myself – have seen it heal a plethora of challenging skin issues as well as visibly reverse signs of ageing, often within days. Now, the ‘next generation’ has been created to only better these results.”
